The global near-infrared imaging market is projected to reach USD 471.2 million by 2020, at a CAGR of 8.8% from 2015 to 2020
By application, the near-infrared imaging market has been segmented into in vivo imaging, cancer surgeries, cardiovascular surgeries, gastrointestinal surgeries, plastic/reconstructive surgeries, and others. The end users of near-infrared imaging devices are hospitals and research labs.
North America contributed the largest share to the near-infrared imaging market in 2014. The large share is attributed to increasing cancer cases, increasing technological advancements, and advantages offered by near-infrared imaging devices over other imaging methods.
The report also provides a detailed competitive landscape of companies operating in this market. Segment and country specific company shares, news & deals, mergers & acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies are detailed. The major players profiled in the global near-infrared imaging market report include Biospace Lab (France), Fluoptics (France), Mizuho Corporation (Japan), Li-Cor, Inc. (U.S.), Bruker Corporation (U.S.), Carl Zeiss Meditec AG (Germany), Novadaq Technologies Inc. (Canada), Hamamatsu photonics K.K. (Japan), Karl Storz GmbH & Co. KG (Germany), PerkinElmer Inc. (U.S.), Promega Corporation (U.S.), and Miltenyi Biotech (Germany).
